CTXR icon

Citius Pharmaceuticals
CTXR

Overview Fund Activity

11 hedge funds and large institutions have $3.58M invested in Citius Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$2.47M
2
SM
2
Sabby Management
Florida
$640K
3
MIM
3
Miller Investment Management
Pennsylvania
$15K
4
VF
4
Virtu Financial
New York
$13K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$360K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$0
3
UBS Group
3
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AC
1
Armistice Capital
New York
$2.47M 2,197,385 +2,197,385 New
SM
2
Sabby Management
Florida
$640K 845,432 +845,432 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$360K 467,228 +14,072 +3%
BAAM
4
Baker Avenue Asset Management
California
$70K 92,878 +8,000 +9%
MIM
5
Miller Investment Management
Pennsylvania
$15K 20,000 +20,000 New
VF
6
Virtu Financial
New York
$13K 16,519 +16,519 New
RJA
7
Raymond James & Associates
Florida
$9K 12,000 – –
Bank of America
8
Bank of America
North Carolina
$5K 5,569 +3,200 +135%
Wells Fargo
9
Wells Fargo
California
$2K 2,000 – –
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$1K 1,000 – –
HCM
11
Hilton Capital Management
New York
$1K 667 – –
Renaissance Technologies
12
Renaissance Technologies
New York
– – -51,333 Closed
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
– – -13,938 Closed
UBS Group
14
UBS Group
Switzerland
– – -3,647 Closed
CFGS
15
Concourse Financial Group Securities
Alabama
– – – –